Home Contact
Login   |  Tell a Friend
Financial Optimization through Technology Innovation
mutual fund
 Top Fund Managers
Latest Mutual Fund News Latest Mutual Fund News

Financial Advisor Sponsor:Christine F. Heim, Managing Director


 Bookmark this site!
Follow FundMojo on Twitter
Get Fund Information

Get Stock News

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | JGLIX Insights | JGLIX Score | JGLIX Performance | JGLIX Manager | JGLIX News | JGLIX Allocation | JGLIX Holdings Change

Mutual Fund Insights: Janus Aspen Global Life Sciences Inst Fund (JGLIX)

In-depth Analysis of Janus Aspen Global Life Sciences Inst Fund (JGLIX)

Mutual fund chart: Janus Aspen Global Life Sciences Inst Fund (JGLIX)

3 months
6 months
1 year
3 year
5 year

See Janus Aspen Global Life Sciences Inst Fund (JGLIX) performance details as of February 28, 2010

  

    Last Trade: $10.72 on 3/19/2010, Change: -0.02 (-0.19%)

  

Fund Manager - Andrew Acker

Fund Manager Tenure: 5.4 years
Fundmojo Fund Grade: B (Score: 0.69)     (What does this score mean?)
Andrew Acker joined Janus Capital in 1999 as a securities analyst. Andrew Acker is a portfolio manager at the firm. Andrew Acker holds the Chartered Financial Analyst designation.  Get more insights on Andrew Acker

  

What we like about Janus Aspen Global Life Sciences Inst Fund (JGLIX) What we like about Janus Aspen Global Life Sciences Inst Fund (JGLIX)

Data for Janus Aspen Global Life Sciences Inst Fund (JGLIX) as of February 28, 2010

  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) management has been with Janus Aspen Global Life Sciences Inst Fund for 5.4 years
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has good short-term performance (1-year return 40.59% vs 40.03 % Health category average)
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has good mid-term performance (3-year return 1.93% vs 0.87 % Health category average)
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has good Long-term performance (5-year return 6.48% vs 4.77 % Health category average)
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) ratio of up-years vs down years is greater than 2
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has an annual stock turnover rate of 87.00% vs Health average of 169.11%. It is good that Janus Aspen Global Life Sciences Inst management does not trade extensively for its return.
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) is less volatile than its peers as it has a 3-year Standard Deviation of 18.07, lower than category average of 18.82
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has a lower management fee than its Health average: 1.24% vs 1.98%
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

  

What we are cautious about Janus Aspen Global Life Sciences Inst Fund (JGLIX) What we are cautious about Janus Aspen Global Life Sciences Inst Fund (JGLIX)

Data for Janus Aspen Global Life Sciences Inst Fund (JGLIX) as of February 28, 2010

  • Janus Aspen Global Life Sciences Inst Fund is a focused fund with 30.98% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
  • Janus Aspen Global Life Sciences Inst Fund (JGLIX) has a Morningstar rating of 3 and below
See Janus Aspen Global Life Sciences Inst Fund (JGLIX) performance details as of February 28, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

  

Janus Aspen Global Life Sciences Inst Fund (JGLIX) Net Asset

Track net asset change of Janus Aspen Global Life Sciences Inst fund (JGLIX)

DateNet Asset
02/2010$17.49M
01/2010$2.44M
11/2009$2.33M
More historic net asset information on Janus Aspen Global Life Sciences Inst Fund (JGLIX)

  

Janus Aspen Global Life Sciences Inst Fund (JGLIX) Portfolio Allocation

Track portfolio allocation change of Janus Aspen Global Life Sciences Inst fund (JGLIX)

DateCashStockBondOther
09/20091.12%96.23%0%2.66%
06/20090.81%96.63%0%2.56%
03/20090%0%0%0%
Click here to see more historic asset allocation information on Janus Aspen Global Life Sciences Inst Fund (JGLIX)

  

Most Recent Top 10 Holdings in Janus Aspen Global Life Sciences Inst Fund (JGLIX)

Discover what Janus Aspen Global Life Sciences Inst Fund (JGLIX) manager is buying

30-Sep-09
Celgene Corporation [4%]
Roche Holding AG [3.85%]
MERCK CO INC [3.37%]
Gilead Sciences, Inc. [3.24%]
Genzyme Corporation [3.22%]
WYETH [3.14%]
CVS CAREMARK CP [2.92%]
Alexion Pharmaceuticals, Inc. [2.58%]
ABBOTT LABORATORIES [2.57%]
UNITEDHEALTH GROUP [2.35%]

30-Jun-09
Celgene Corporation [4%]
Roche Holding AG [3.85%]
MERCK CO INC [3.37%]
Gilead Sciences, Inc. [3.24%]
Genzyme Corporation [3.22%]
WYETH [3.14%]
CVS CAREMARK CP [2.92%]
Alexion Pharmaceuticals, Inc. [2.58%]
ABBOTT LABORATORIES [2.57%]
UNITEDHEALTH GROUP [2.35%]

31-Mar-09
Price/Earnings [0%]
N/A [0%]
N/A [0%]
Median Market Cap [0%]
N/A [0%]
N/A [0%]
N/A [0%]



Click here for Stock Holding Change Map in Janus Aspen Global Life Sciences Inst Fund (JGLIX)

  

Related books and products to Janus Aspen Global Life Sciences Inst Fund (JGLIX)

  

Latest News on Janus Aspen Global Life Sciences Inst (JGLIX)

See what is happening with Janus Aspen Global Life Sciences Inst Fund (JGLIX)

 

Books and Resources

 

 

See more information on Janus Aspen Global Life Sciences Inst Fund (JGLIX)